Brief: Genor Biopharma Says On 2 Aug, Co Entered License Deal And Stock Purchase Deal With TRC 2004
Aug 5 (Reuters) - Genor Biopharma Holdings Ltd
6998.HK :
* ON 2 AUGUST, CO ENTERED LICENSE AGREEMENT AND STOCK
PURCHASE
AGREEMENT WITH TRC 2004
* TO GRANT TRC 2004 EXCLUSIVE WORLDWIDE LICENSE TO DEVELOP,
USE,
MANUFACTURE, COMMERCIALIZE AND OTHERWISE EXPLOIT GB261
Further company coverage: 6998.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Edding Genor group
See all newsBrief: JHBP CY Says Chairman And CEO Ni Xin To Buy Shares Up To USD 1 Million From Aug 31, 2026
Brief: Edding Genor Group Expects Revenue Of RMB850 MLN-RMB900 MLN For HY
Brief: Jhbp Cy Disposal Of Equity Interest In Candid Therapeutics
Edding Genor climbs on approval of clinical trial of cancer drug in China
Brief: JHBP CY's Phase Ib/Ii Clinical Trial Of Gb268 Obtains IND Approval By NMPA